Capital Counsel’s Core Laboratories CLB Stock Holding History

Capital Counsel’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-47,627	Closed	-$5.52M	–	55
2018 Q3	$5.52M	Sell	47,627 -36,739	-44%	-$4.14M	0.38%	24
2018 Q2	$10.6M	Sell	84,366 -1,275	-1%	-$155K	0.81%	18
2018 Q1	$9.27M	Sell	85,641 -1,358	-2%	-$150K	0.75%	18
2017 Q4	$9.53M	Sell	86,999 -23,123	-21%	-$2.31M	0.78%	19
2017 Q3	$10.9M	Sell	110,122 -9,890	-8%	-$959K	0.97%	18
2017 Q2	$12.2M	Sell	120,012 -2,678	-2%	-$289K	1.11%	17
2017 Q1	$14.2M	Sell	122,690 -3,756	-3%	-$437K	1.35%	17
2016 Q4	$15.2M	Buy	126,446 +2,368	+2%	+$262K	1.57%	18
2016 Q3	$13.9M	Buy	124,078 +17,700	+17%	+$2.04M	1.24%	17
2016 Q2	$13.2M	Sell	106,378 -36,290	-25%	-$4.38M	1.22%	17
2016 Q1	$16M	Sell	142,668 -6,585	-4%	-$684K	1.45%	17
2015 Q4	$16.2M	Sell	149,253 -5,685	-4%	-$651K	0.86%	24
2015 Q3	$15.5M	Buy	154,938 +1,914	+1%	+$208K	0.81%	26
2015 Q2	$17.5M	Sell	153,024 -3,706	-2%	-$449K	0.86%	24
2015 Q1	$16.4M	Sell	156,730 -101,736	-39%	-$10.8M	0.78%	24
2014 Q4	$31.1M	Sell	258,466 -298,074	-54%	-$39.2M	1.46%	21
2014 Q3	$81.5M	Sell	556,540 -20,900	-4%	-$3.23M	4.58%	10
2014 Q2	$96.5M	Buy	577,440 +48,165	+9%	+$8.57M	5.26%	9
2014 Q1	$105M	Buy	529,275 +32,999	+7%	+$6.23M	5.73%	7
2013 Q4	$94.8M	Sell	496,276 -12,604	-2%	-$2.35M	5.31%	7
2013 Q3	$86.1M	Buy	508,880 +258,284	+103%	+$40.1M	5.02%	8
2013 Q2	$38M	Buy	+250,596	New	+$35.5M	2.28%	17

Other funds holding CLB

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Capital Counsel's CLB Position: Q4 2018 in Review

Capital Counsel sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 47,627 shares — an estimated $5.52M sold.

Capital Counsel first reported a position in CLB in Q2 2013 and held it in 22 quarters. The position peaked at $105M in Q1 2014. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

Capital Counsel reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
Capital Counsel sold 47,627 Core Laboratories shares in Q4 2018, an estimated $5.52M.
Capital Counsel first reported a position in Core Laboratories in Q2 2013 and held it in 22 quarters.
Capital Counsel's Core Laboratories position peaked at $105M in Q1 2014.
320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on Capital Counsel's 13F filing for Q4 2018, filed 13 Feb 2019.